Elevated levels of SUMO1-related p65 SUMOylation in cancer tissues may enhance the nuclear translocation of p65 and activation of the NF-κB signalling pathway, promoting HCC invasion and metastasis, thus accelerating HCC progression (Liu et al., 2020). Here, SUMO1 is linked to hepatocellular carcinoma.